Antibiotic resistance in foodborne pathogens, an ongoing public health threat, continued to show both positive and challenging trends in 2013, according to human illness data posted online today by the Centers for Disease Control and Prevention (CDC). Efforts are underway to curb the injudicious use of antibiotics, but each year, antibiotic-resistant infections from foodborne germs cause an estimated 440,000 illnesses in the United States.
The National Antimicrobial Resistance Monitoring System (NARMS) tracks changes in the antibiotic resistance of six types of common foodborne germs found in ill people, retail meats, and food animals. In 2013, NARMS tested more than 5,000 germs from sick people for antibiotic resistance and compared them with previous years’ data to assess changes in resistance patterns.
Among the findings in the new NARMS report on human illnesses:
The good news is that multidrug resistance (resistance to three or more classes of antibiotics) in Salmonella overall stayed steady, remaining at 10 percent of infections. However, resistance in some types of Salmonella is increasing. For example, multidrug resistance in a common Salmonella serotype called I4,[5],12:i:- was 46 percent, more than double the rate from two years before. In the United States, resistance in this serotype to four drugs (ampicillin, streptomycin, sulfonamides, and tetracycline) rose from 18 percent in 2011 to 46 percent in 2013. Human illness with this serotype has been linked to animal exposure and consumption of pork or beef, including meats purchased from live animal markets.
NARMS also tests Campylobacter, another germ that is transmitted by food. One in four Campylobacter samples from sick people are still resistant to quinolones like ciprofloxacin.
Most Salmonella and Campylobacter infections cause diarrheal illness that resolves within a week without antibiotics. These germs can also cause infection of the bloodstream and other sites. In more serious infections and when germs are resistant, antibiotics may be ineffective, increasing the chance of a severe illness.
The 2013 NARMS Annual Human Isolates Report is now available at http://www.cdc.gov/narms/reports/index.html.
NARMS is a collaboration among state and local public health departments, CDC, the U.S. Food and Drug Administration (FDA), and the U.S. Department of Agriculture (USDA). NARMS helps protect public health by providing information about bacterial resistance, the ways in which resistance is spread, and how resistant infections differ from susceptible infections. Understanding trends in antibiotic resistance helps doctors to prescribe effective treatment and public health officials to investigate outbreaks faster.
The FY 2016 President’s Budget requests additional funding for CDC to improve early detection and tracking of drug-resistant Salmonella and other urgent antibiotic resistance threats. The proposed initiative would allow CDC to check nearly every Salmonella sample and many more Campylobacter samples for resistance more quickly.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.